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Objective: To assess for the first time the morphology of the lymphatic system in patients with posttraumatic edema of the
lower extremities by magnetic resonance (MR) imaging using the interstitial lymphangiography technique
Materials and Methods: Six patients with posttraumatic edema in eight of their 12 lower extremities were examined byMR
lymphangiography. Eighteen mL of gadoteridol and one mL of mepivacainhydrochloride 1% were subdivided into 10
portions and injected intracutaneously.MR imaging was performedwith a 1.5-T system equippedwith high-performance
gradients. For MR lymphangiography, a 3D-spoiled gradient-echo sequence was used.
Results: In five of the eight (63%) traumatized lower extremities, enlarged lymphatic vessels were detected, with the largest
diameter measuring 5 mm. Additionally, a fast lymphatic outflow was observed in seven of the eight (88%) traumatized
legs with enhancement of the inguinal lymph nodes already in the first image acquisition 15 minutes after contrast
material injection. In two of the eight (25%) traumatized lower extremities, an extensive network of collateral lymphatic
vessels was detected at the level of the calf. In both extremities, lymphatic collateralization involved not only the epifascial
but also the subfascial lymphatic system. In one patient, who sustained a trauma of the left lower leg with tibial fracture,
a small aneurysmatic widening of 7 mm could be detected at the middle level of the calf.
Conclusion: MR lymphangiography is a safe and accurate minimal-invasive imaging modality for the evaluation of the
lymphatic circulation in patients with posttraumatic edema of the lower extremities. If the extent of lymphatic damage is
unclear at the initial clinical examination or requires a better definition for optimal therapeutic planning, MR
lymphangiography is able to identify the anatomic and physiological derangements and to establish an objective baseline.
(J Vasc Surg 2009;49:417-23.)Mechanical trauma of the soft tissue and skeleton of the
lower extremities is often accompanied by permanent
edema at the region of the trauma and the parts distal parts
to it.1 According to Szczesny and Olszewski,1 around 20%
to 25% of patients with mechanical trauma of the legs suffer
from this complication, and the extent of the edema is
dependent upon the type and the extent of the trauma.
Treatment of this condition has also been reported to be
difficult, long-lasting, and not very successful. The patho-
mechanism and, especially, factors responsible for its per-
sistence are, to date, not clarified. However, several studies
indicate that besides affecting the venous system with
thrombotic events, an injury of the lymphatic system with
subsequent tissue fluid and lymph stagnation is likely an
additional cause for this edema.2-5
Up to now, conventional lymphography and lympho-
scintigraphy have been the methods of choice to assess the
lymphatic system in patients with posttraumatic edema of
the lower extremities.6-15 However, radiation exposure,
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bolism have limited the clinical applicability of conven-
tional lymphography. Lymphoscintigraphy also has the dis-
advantage of ionizing radiation and a low spatial and
temporal resolution. In contrast, magnetic resonance lym-
phangiography (MRL) with intracutaneous application of a
water-soluble, paramagnetic contrast agent has proven to
be a safe and accurate diagnostic imaging method for the
delineation of pathologically modified lymphatic pathways
with a high resolution.16-19 The purpose of this study was
to assess for the first time the morphology of the lymphatic
system in patients with posttraumatic edema of the lower
extremities by magnetic resonance imaging using the inter-
stitial lymphangiography technique.
MATERIALS AND METHODS
Patients. Between April 2006 and April 2007, six
patients (age 35-75 years; mean age, 48 years; two female,
four male) with clinically proven edema in eight of their 12
lower extremities were referred for MRL and entered into
this study (Table I). The study had been approved by our
institutional review board, and informed consent had been
obtained from all patients prior toMR imaging. The edema
of the traumatized legs was unilateral in four patients and
bilateral in two patients. The development of the edema in
four patients (two with unilateral edema and two with
bilateral edema) was associated with a car accident with
direct trauma to the lower extremities, pelvic region, and
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veloped after forcible trauma with a metal bar in the area of
the right groin while one patient with a lower leg amputa-
tion due to a bomb explosion in World War II developed
edema in the stump of the remaining upper leg. All patients
noticed swelling of the traumatized legs within weeks of the
trauma, which gradually increased over time. The time
interval between the injury and the MRL varied for five
patients between nine months and six years three months
(mean, two years eight months). For the injured patient in
WorldWar II, the time interval between the trauma and the
MRL was about 65 years.
To our knowledge, there was no history of infection or
deep vein thrombosis in any of the patients before or after
the trauma and none of the patients were treated with
anticoagulants on a regular basis. Additionally, at the time
of MRL performance, five of the six patients underwent
colorflow duplex scanning demonstrating no signs of
thrombotic events. Siimilarly, pain, redness, and elevated
skin temperature were absent at the time of MRL scanning,
excluding complex regional pain syndrome.
After MRL, four patients received conservative treat-
ment with intensive complex decongestive therapy as in-
patients. Two patients underwent microsurgical proce-
dures: a lymphatic vessel transplantation in the patient who
sustained a forcible trauma with a metal bar in the area of
the right groin and a lympho-venous anastomosis at the
level of the lower leg in a patient with extensive soft tissue
injury. These two patients were also advised to complete
their treatment after hospital release with complex decon-
gestive therapy three times per week in an ambulatory
setting.
Contrast media. In each patient, a total amount of 18
mL contrast material (Gadoteridol, Prohance, Bracco-Byk
Gulden, Konstanz, Germany) and 2 mL mepivacainhydro-
chloride 1% were subdivided into 10 portions and injected
into the dorsal aspect of each foot in the region of the four
interdigital webs and medial to the first proximal phalanx.
In the patient with the amputated left lower leg, four
contrast media depots were placed in the area of the stump.
Gadoteridol is a non-ionic, extracellular, micromolecular,
water-soluble contrast material for magnetic resonance im-
aging. It has paramagnetic properties with a gadolinium
Table I. Magnetic resonance lymphangiography
examinations
MRL examinations Number
Total number of examined patients 6
Patients with unilateral posttraumatic edema 4
Patients with bilateral posttraumatic edema 2
Total number of examined lower extremities 12
Examined lower extremities with posttraumatic
edema 8
Examined lower extremities without posttraumatic
edema 4(Gd) concentration of 0.5 M. Gadoteridol is usually ap-plied intravenously and cleared from the body by glomer-
ular filtration. However, in prior studies, Gadoteridol has
been shown to be safe and feasible for MRL after intracu-
taneous injection without any adverse effects or signs of
cutaneous or systemic fibrosis.16-19
MR imaging examinations. MRL was conducted
with a 1.5-T system (Avanto; Siemens Medical Systems,
Erlangen, Germany) and three locations were examined:
first, the lower leg and foot region; second, the upper leg
and the knee region; and third, the pelvic region and the
proximal upper leg. The imaging protocol consisted of a
heavily T2-weighted 3D-TSE MRI sequence (TR/TE:
2000/694; flip angle: 180°; matrix: 256  256, band-
width: 247 Hz/pixel; 6/8 rectangular field of view 480
mm; slices: 96; voxel size: 2.0 1.9 1.7 mm; acquisition
time: 4 min 48 sec) to evaluate the extent and distribution
of the edema. For MRL, a 3D spoiled gradient-echo se-
quence (Volumetric Interpolated Breathold Examination,
VIBE) was performed (TR/TE: 3.58/1.47; flip angle: 35°;
matrix: 448  448, bandwidth: 490 Hz/pixel; 6/8 rect-
angular field of view with a maximum dimension of 500
mm; slices: 128; voxel size: 1.2  1.1  1.2 mm; acquisi-
tion time: 1 min 40 sec). To improve vessel-to-background
contrast and to facilitate fast and easy interpretability of
data, unenhanced ‘mask’ scans were subtracted from con-
trast-enhanced datasets (image subtraction).20-23
Image analysis. The enhancement of gadoderitol in
the lymphatic pathways, inguinal lymph nodes and veins
was assessed by two authors. Lymphatic vessels were iden-
tified and differentiated from veins based on their beaded
appearance. The lymphatic vessels were also evaluated for
size and collaterals and their diameter measured. An area of
progressive dispersion of the contrast media into the soft
tissues was regarded as dermal back-flow. A diagnosis was
reached by consensus.
RESULTS
The edema of the traumatized legs, detected by the
3D-TSE MRI sequence, was unilateral in four patients and
bilateral in two patients, hence detected in eight of the
examined 12 lower extremities. In seven of the lower
extremities, the edema demonstrated an epifascial distribu-
tion (Fig 1A), while in one lower extremity, an epifascial as
well as subfascial component could be detected.
In five of the eight (63%) traumatized lower extremi-
ties, the VIBE-sequence revealed lymphatic vessels with a
diameter between 3 mm and 5 mm (Table II, Fig 1B, 2A,
2B) while in three of the eight (37%) traumatized lower
extremities, the lymphatic vessels diameter ranged between
1 mm and 3 mm (Table II, Fig 2C). Additionally, the
dilatation of the lymphatic vessels presented as a diffuse
condition, essentially below and at the level of trauma.
Furthermore, a fast lymphatic outflow was observed in
seven of the eight (88%) traumatized legs with enhance-
ment of the inguinal lymph nodes in the first image
acquisition 15 minutes after contrast material injection
(Table II). Accompanying venous enhancement was re-
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lower extremities (Fig 1B).
In two of the eight (25%) traumatized lower extremi-
ties with severe soft tissue injury, an extensive network of
collateral lymphatic vessels was detected at the level of the
calf (Table II, Fig 2A, 2B). In both extremities, lymphatic
collateralization involved not only the epifascial but also the
subfascial lymphatic system (Fig 2C). Furthermore, lymph
flow obstruction due to damaged epifascial lymphatic ves-
sels was demonstrated in one lower extremity, resulting in
deteriorated lymphatic outflow and delayed enhancement
of the inguinal lymph nodes in the 35-minute acquisition
post-contrast media injection. Interestingly, the enhance-
ment of the inguinal lymph nodes in the second extremity
with an extensive network of collateral lymphatic vessels
(patient with bilateral edema) was not delayed and was
detected in the first 15-minute acquisition post-contrast
media injection, potentially due to the lymphatic outflow
compensation of the deep lymphatic system.
In one patient, who sustained a trauma of the left lower
leg with tibial fracture, a small aneurysmal widening of a
lymphatic vessel up to a diameter of seven mm could be
detected at the middle level of the calf (Fig 3). Further-
more, the lateral aspect of the lymphatic system was en-
hanced in addition to the ventro-medial bundle in this
patient. In contrast, in one patient with direct trauma to the
upper legs, pelvic and lumbo-sacral region with cutaneous
and subcutaneous soft tissue injuries but without pelvic
fracture MRL revealed a bilateral epifascial edema with fast
lymphatic outflow, resulting in an enhancement of the
inguinal lymph nodes 15 minutes after contrast material
injection. The diameter of the lymphatic vessels measured
up to 2 mm at the level of the lower legs in this patient but
no lymphatic collateralisation was noted.
Finally, MRL examinations in the three lower extrem-
ities without edema demonstrated a normal lymphatic out-
flow without manifestations of lymph flow obstruction,
Fig 1. A 75-year-old man with amputed left lower leg due to a
bomb explosion in World War II with consecutive development of
a lymphedema in the stump of the remaining upper leg.A,Coronal
heavily T2-weighted 3D-TSE source image demonstrates epifas-
cial lymphedema of the stump (arrows). B, Frontal 3D spoiled
gradient-echo magnetic resonance lymphangiography (MRL)
MIP-image, obtained 25 minutes after gadoteridol injection,
clearly depicts several enlarged lymphatic vessels up to a diameter
of 3 mm (small arrows) at the lever of the left stump originating
from the contrast media injection depots (aterisks). Additionally,
several enlarged lymphatic vessels are detected at the level of the
clinically inconspicuous right lower leg (large arrows). Note the
parallel enhancing vein, which shows a lower signal intensity
(arrowhead). C, Angled spoiled gradient-echo MRL MIP-image,
obtained 25 minutes after gadoteridol injection, reveals several
enlarged lymphatic vessels up to a diameter of 3 mm at the level of
both knees and upper legs (arrows). Note the parallel enhancing
vein at the level of the left upper leg, which shows a lower signal
intensity (arrowhead). Early enhanced lymph nodes are demar-
cated at the level of both inguinal regions (asterisks).
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and 2 mm. Interestingly, the clinically inconspicuous right
lower extremity of the 75-year old man with the amputated
left lower leg showed an unclear enlargement of lymphatic
vessels up to a diameter of 4 mm (Fig 2A).
DISCUSSION
Etiological classification differentiates between primary
(idiopathic) and secondary lymphedema, so that the post-
traumatic lymphedema in the patients presented here can
be regarded as secondary lymphedema.24 Regardless, in
both types of lymphedema, lymphostasis leads to a devel-
opment of high protein edema, accumulation of immune
cells, fibrosclerosis, and deposition of fat. If adequate treat-
ment is not undertaken, the patient will finally develop
lymphostatic elephantiasis and become disabled.24
Up to now, conventional lymphography and lympho-
scintigraphy have been the primary imaging tools in evalu-
ating the degree of lymphatic damage in patients with
Fig 2. A 40-year-old woman with unilateral secondary lymphed-
ema of the left lower leg due to direct trauma in a car accident.
A, Frontal 3D spoiled gradient-echo magnetic resonance lym-
phangiography (MRL) MIP-image, obtained 35 minutes after ga-
doteridol injection, clearly depicts several enlarged lymphatic ves-
sels at the level of the left foot and lower leg with a network of
collateral formations (arrows). Note the parallel enhancing veins,
which show a lower signal intensity (arrowheads). B, Angled 3D
spoiled gradient-echo MRL MIP-image, obtained 35 minutes
after gadoteridol injection, clearly depicts seveleral enlarged lym-
phatic vessels at the level of the left foot and lower leg with a
network of collateral formations (arrows). The collateralization
involves hereby both the epifascial and subfascial lymphatic system.
Note the parallel enhancing vein, which shows a lower signal
intensity (arrowhead).C, Frontal 3D spoiled gradient-echo source
image, obtained 35 minutes after gadoteridol injection, clearly
delineates the enlarged epifascial lymphatic vessels (arrowheads),
subfascial lymphatic vessels (asterisk), and the perforating lymphat-
ics (arrow), combining the epifascial with the subfascial lymphatic
system. Note the close anatomic relationship of the deep lymphatic
Table II. Magnetic resonance lymphangiography
findings in eight examined lower extremities with
posttraumatic edema
MRL findings
Number of
extremities
Lymphatic vessel diameter of 1 mm - 3 mm 3 (37%)
Lymphatic vessel diameter of 3 mm - 5 mm 5 (63%)
Fast lymphatic outflow (enhancement of inguinal
LN 15 min post injection) 7 (88%)
Delayed lymphatic outflow (enhancement of
inguinal LN 35 minutes post injection) 1 (13%)
Concomitant venous enhancement 8 (100%)
Collateral vessels indicating lymphatic outflow
obstruction 2 (25%)
LN, lymph node.vessels with the tibia.
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Conventional lymphography offers the highest concentra-
tion of the contrast media in lymphatic vessels and nodes.
However, radiation exposure and potential side effects,
such as pulmonary embolism, have limited its clinical use.
Indeed, some authors are even of the opinion that direct
lymphography is obsolete in patients with lymphedema
because the oily contrast media damages the lymphatic
vessels and worsens the lymphedema.24
Lymphoscintigraphy represents the current gold stan-
dard in the evaluation of the lymphatic pathways, although
Fig 3. A 35-year-old man with unilateral secondary lymphedema
due to a car accident with direct trauma to the left lower leg with
tibial fracture. Frontal 3D spoiled gradient-echo magnetic reso-
nance lymphangiography (MRL) MIP-image, obtained 35 min-
utes after gadoteridol injection, reveals a small lymphatic aneurysm
of 7 mm at the middle level of the calf. Furthermore, the lateral
aspect of the lymphatic system was enhanced in addition to the
ventro-medial bundle.it also has the disadvantage of ionizing radiation and pro-vides low spatial and temporal resolution. Despite these
disadvantages, many studies have demonstrated lympho-
scintigraphy to be a useful method to evaluate functional
disturbances of the lymphatic system, using the clearance
ratio, and up to now, no alternative imaging modality exists
to answer this functional question. Although lymphoscin-
tigraphy has limitations to visualize the lymphatic vessels
with a high resolution, it is also possible to demonstrate
dermal back-flow areas using this technique indicating lym-
phatic outflow obstruction and thereby presenting the cli-
nician valuable information for future treatment options.
In contrast, the advantage of MRL, as shown here, is
the aquisition of high resolution images of the lymphatic
vessels and the lack of radiation. Furthermore, functional
information regarding the lymphatic outflow can be
achieved, since image acquisitions take place 15, 25, 35, 45,
and 55 minutes after contrast material injection. However,
the reliability of the functional information obtained from
MRL has to be validated in further studies comparingMRL
with the gold standard lymphscintigraphy. Regardless, in
patients with persistent post-traumatic edema, it appears
that MRL can be used to exclude or to confirm a traumatic
affection of the lymphatic vessels and to determine the
extent of the lymphatic vessel injury (eg, are just the epifas-
cial lymphatic pathways affected or additionally the subfas-
cial system). Other important questions can also be an-
swered (eg, whether a sufficient collateralisation has been
established or how dilated the lymphatic vessels are). A
major advantage of MRL (compared with lymphoscintig-
raphy) is also the possibility to precisely visualize and delin-
eate areas of dermal back-flow and the small lymphatic
vessels, thereby obtaining the functional information dem-
onstrated by lymphoscintigraphy and describing the num-
ber, appearance, and anatomic course of the lymphatic
vessels. Finally, with MRL, it is also possible to exactly
evaluate and delineate the distribution of the lymphedema
using the VIBE- and T2-weighted 3D-TSE sequence, in
order to optimize complex decongestive therapy or to
select patients suitable for microlymphatic surgery.
Similar to prior MRL studies, accompanying enhance-
ment of veins was seen in all extremities, as Gadoteridol has
micromolecular properties and is absorbed by the lym-
phatic and venous system.However, baseline- and 3D-MIP
images at different angles of view helped to identify the
lymphatic vessels and differentiate them from veins based
on their beaded appearance.16-19 Foeldi et al reported that
lymphatic vessels respond to the lymphatic load in patients
with secondary lymphedema in the first stages of the disease
with vessel dilatation and a fast lymphatic outflow24 while
in the later stages of the problem, the lymphatic vessels
increasingly decompensate with valvular insufficiency,
lymph stasis, and delayed lymphatic outflow. At this later
stage, MRL findings should demonstrate a single fluid
column with no visibility of a beaded appearance of the
lymphatics. However, as a fast lymphatic outflow was dem-
onstrated in 88% of the traumatized legs in the current
study, this stage of the disease had not been reached by our
patients and therefore the use of a “beaded appearance” as
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ate them from veins appeared acceptable.
Several previous studies have strongly linked nephro-
genic systemic fibrosis (NSF) to intravenous gadolinium
administration for magnetic resonance imaging.25-27 Addi-
tionally, in a recent advisory, the Food and Drug Adminis-
tration stated that all gadolinium-containing chelates are
potentially associated with nephrogenic systemic fibrosis.
Most reported cases are linked to gadodiamide (Omniscan)
and gadopentetate dimeglumine (Magnevist) and the pro-
posed cause of NSF is release of free Gd3 into tissues in
patients with impaired renal function.28 In contrast, Gado-
teridol (Prohance) has a cyclic structure, making it less
likely for free Gd3 to be released, and there is only one
reported case of NSF associated with gadoteridol use
alone.28 Furthermore, to our knowledge, there is no re-
ported case in the medical literature of local or systemic
fibrosis after intracutaneous injection of gadolinium, and
prior MRL studies with the intracutaneous injection tech-
nique, using gadodiamide and gadoteridol as contrast
agents, have not shown any adverse effects or signs of
cutaneous or systemic fibrosis. Thus, MRL with intracuta-
neous injection of Gadoteridol seems to be a safe imaging
method for the patient with posttraumatic lymphedema.
Czepelenko et al conducted direct lymphography in 21
patients 1.5 years after open fractures of the lower limb,
which were complicated by malunion, protracted wound
healing, and scarring of the soft tissues.6,7 Lymphatic out-
flow obstruction, dilatation of lymphatic vessels, and lym-
phatic collateralizations were observed, similar to the re-
sults from MRL examinations presented here, which were
conducted between nine months and 65 years after injury.
Czepelenko et al also demonstrated dermal back-flow areas,
which were not observed in our patient series. Several other
lymphoscintigraphy studies examining patients after me-
chanical and operative injuries to the legs, detected in-
creased lymphatic formation and flow10,11 or enlargement
of the regional lymph nodes,12-14 similar to our findings.
Szczesny et al assumed that enlargement of the lymphatic
vessels, as was observed in the patients examined withMRL
in this study, may be caused by increased lymphatic forma-
tion and tissue fluid in the area of the trauma, as well as by
paresis of the lymphatic vessel due to locally formed inflam-
matory substances.15 In the current study, MRL also dem-
onstrated interruption of the lymphatic vessels in two of the
traumatized lower extremities (25%) at the level of the calf
with an extensive network of collateral lymphatic vessels.
While in one of these two legs the inguinal lymph nodes
showed an enhancement 35 minutes after contrast material
injection, indicating delayed lymphatic outflow, the ingui-
nal lymph nodes were enhanced already 15 minutes after
contrast material injection in the other patient, possibly due
to the lymphatic outflow compensation of the deep lym-
phatic system. This observation describes impressively the
capability of the deep lymphatic system to support the
lymphatic transport to a certain degree.
Baulieu et al performed lymphoscintigraphy in 32 pa-
tients with tibial fractures and found that the alterations ofthe lymphatic system were significantly more common in
the group who developed edema at three months com-
pared with the group without edema.8 They concluded
that early lymphoscintigraphy is a safe test for the predic-
tion of residual edema after tibial fractures. Similarly, Szc-
zesny and Olszewski examined 21 patients with closed
lower limb bone fractures and soft tissue injuries with
lymphoscintigraphy9 but found no interruption of calf or
thigh lymphatic vessels on lymphoscintigraphies in any of
the patients. However, Szczesny and Olszewski detected
dilatation of lymphatic vessels in all (100%) examined ex-
tremities and a decrease in lymphatic flow rate in these
vessels.9 In the current study, MRL examinations showed
enlarged lymphatic vessels in 63% of the traumatized lower
extremities, with the largest diameter measuring 5 mm.
The dilatation of the lymphatic vessels was also demon-
strated to be a diffuse condition, essentially below and at
the level of trauma. Interestingly, the clinically inconspicu-
ous right lower extremity of the 75-year old man with
amputated left lower leg showed an unclear enlargement of
lymphatic vessels up to a diameter of 4 mm.
Szczesny and Olszewski also reported an enlargement
of inguinal lymph nodes in 62% of cases and rapid visual-
ization (within 30 minutes) of lymphatic vessels of the
injured extremity in eight patients (38%), while in 12
patients (57%), lymphatic vessels were visualized after 45
minutes, simultaneous with the contralateral limb. In two
patients, a network of superficial lymphatic vessels was seen,
indicating local obstruction. Similarly, in the current study,
MRL revealed a fast lymphatic outflow in 88% of the
traumatized legs with enhancement of the inguinal lymph
nodes in the first image acquisition 15 minutes after con-
trast material injection. These observations correlate well
with the theory by Foeldi et al, that the lymphatic vessels
respond to the lymphatic load in patients with secondary
lymphedema (eg, posttraumatic lymphedema) in the first
stages of the disease with a dilatation and a fast lymphatic
outflow.24 Finally, Szczesny and Olszewski reported that
the type of lymphatic system changes were similar, irrespec-
tive of whether a fracture or only soft tissue injury existed
and whether the injury was complicated or not by throm-
bosis of the venous system.9 These observations were con-
firmed in animal experiments using intravital fluorescence
and standardized mechanical injury of hind limbs29 so that
Szczesny and Olszewski concluded, in summary, that both
clinical and experimental observations support the theory
of an inflammatory process being responsible for the per-
sistent posttraumatic edema of lower extremities.9
In conclusion, MRL is a safe and accurate diagnostic
imaging method for the evaluation of the lymphatic circu-
lation in patients with posttraumatic edema of the lower
extremities. If the extent of lymphatic damage in patients
with posttraumatic edema is unclear by clinical examination
alone or requires a better definition for optimal therapeutic
planning (complex decongestive therapy, microvascular
surgery), MRL is an excellent, minimally-invasive imaging
modality with a high resolution to identify the anatomic
and physiological derangements of the lymphatic system
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the minimal-invasiveness and lack of radiation associated
with the procedure, diagnostic follow-up MRLs can be
performed routinely and with no risk for the patient.
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